Document is current

Article History

Received: 7 October 2024

Revised: 17 February 2025

Accepted: 22 April 2025

First Online: 8 May 2025

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Financial interests: Kin Sheng Lim is a consultant for Santen, BVI, Alcon, Abbvie, Glaukos and iSTAR, has receiving speaking fees from Santen, AbbVie, Alcon, iSTAR and Glaukos and receives research support from iSTAR and Santen. Julián García-Feijóo is a consultant for Alcon, Abbvie, Glaukos, iSTAR, Alimera, ELIOS, Sight Science and Santen, has receiving speaking fees from Santen, AbbVie, Thea, Alcon, iSTAR, Glaukos and Sight Science. and receives research support from Alcon, Abbvie, Glaukos, ELIOS, iSTAR, Sight Science, Nova EYE (iTrack), AJL, Santen, ZEISS, Heidelberg, J&J, B&L, Thea, AJL, Rayner, Cutting Edge, Physiol, Biotech and Vialase. Karsten Klabe is a consultant for AbbVie, Alcon, Carl Zeiss Meditec, Elios Vision, iStar Medical, Oertli and Vialase, has receiving speaking fees from AbbVie, Alcon, Carl Zeiss Meditec, Elios Vision, iStar Medical, Santen and Vialase, and receives research support from AbbVie, Alcon, Carl Zeiss Meditec, EyeD Pharma and iStar Medical.Non-financial interests: None.